Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Ended earlyNCT00531310
What this trial is testing

Reduced Intensity AlloSCT in(CML) With Persistent Disease

Who this might be right for
Chronic Myeloid Leukemia
Columbia University 5
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)WithdrawnNCT00816413
What this trial is testing

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT00145613
What this trial is testing

Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Secondary AML+7 more
St. Jude Children's Research Hospital 25
Not applicableUnknownNCT05367583
What this trial is testing

Cohort Study Assessing the Treatment Strategy for High-Risk Myelodysplastic Syndromes in Patients Under 70

Who this might be right for
Myelodysplastic Syndromes
University Hospital, Bordeaux 107
Testing effectiveness (Phase 2)Study completedNCT01404741
What this trial is testing

5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
Universitätsklinikum Hamburg-Eppendorf 191
Testing effectiveness (Phase 2)UnknownNCT02145923
What this trial is testing

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Who this might be right for
Neutropenic EnterocolitisMyeloablative Chemotherapy Induced Bone Marrow Aplasia
Burnasyan Federal Medical Biophysical Center 16
Early research (Phase 1)Study completedNCT02342613
What this trial is testing

Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematologic MalignanciesGraft-Versus-Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)Study completedNCT00587054
What this trial is testing

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Who this might be right for
Allogeneic Stem Cell TransplantLeukemiaNon-Hodgkins+3 more
Memorial Sloan Kettering Cancer Center 129
Not applicableEnded earlyNCT00038818
What this trial is testing

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myelogenous LeukemiaMultiple MyelomaNon Hodgkin's Lymphoma+2 more
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00040469
What this trial is testing

Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies

Who this might be right for
Sickle Cell AnemiaHemoglobinopathyThalassemia
Baylor College of Medicine 15
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03779854
What this trial is testing

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+14 more
Fred Hutchinson Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00005622
What this trial is testing

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Testing effectiveness (Phase 2)Ended earlyNCT00074490
What this trial is testing

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

Who this might be right for
LymphomaLeukemiaMyeloproliferative Disorders+2 more
National Cancer Institute (NCI) 442
Testing effectiveness (Phase 2)Study completedNCT00054340
What this trial is testing

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT05352789
What this trial is testing

Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.

Who this might be right for
Haematological MalignancyBone Marrow Transplant ComplicationsStem Cell Transplant Complications+4 more
Nottingham University Hospitals NHS Trust 66
Next Page